p. 91-100
Adipocyte-fatty acid binding protein induces apoptosis in DU145 prostate cancer cells
Marta L. De Santis, Rasha Hammamieh, Rina Das and Marti Jett
Abstract
Full Text (IP)
p. 101-110
Fatty acid synthase as a tumor marker: Its extracellular expression in human breast cancer
Young Y. Wang, Francis P. Kuhajda, Jinong Li, Teia T. Finch, Paul Cheng, Clare Koh, Tianwei Li, Lori J. Sokoll and Daniel W. Chan
Abstract
Full Text (IP)
p. 111-119
Screening for small molecule inhibitors of insulin-like growth factor receptor (IGF-1R) kinase: Comparison of homogeneous time-resolved fluorescence and 33P-ATP plate assay formats
Yan Wang, Michael Malkowski, Judity Hailey, Tammy Turek-Etienne, Tom Tripodi and Jonathan A. Pachter
abstract
Full Text (IP)
p. 121-129
Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture
Piotr Ziolowski, Beata J. Osiecka, Gerhard Oremek, Maciej Siewinski, Krzysztof Symonowicz, Yousif Saleh and Andrzej Bronowicz
Abstract
Full Text (IP)
p. 131-136
Improving the toxicity profile of chemotherapy for advanced ovarian cancer: A potential role for CT-2103
Maurie Markman
Abstract
Full Text (IP)
p. 137-143
Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro
Garret Yount, Yifang Gian, Dan Moore, Dan Basila, Jeremy West, Ken Aldape, Nils Arvold, Noga Shalev and Daphne Haas-Kogan
Abstract
Full Text (IP)
p. 145-154
Ex vivo therapeutic index by drug sensitivity assay using fresh human normal and tumor cells
Andrew G. Bosanquet and Philip B. Bell
Abstract
Full Text (IP)
p. 155-160
Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer
Fumihiro Oshita, Mizuki Ikehara, Akiko Sekiyama, Nobuyuki Hamanaka, Haruhiro Saito, Kouzo Yamada, Kazumasa Noda, Yoichi Kameda and Yohei Miyagi
Abstract
Full Text (IP)
Review
p. 161-166
Targeting K+ channels for cancer therapy
Matteo Conti
Abstract
Full Text (IP)
Rapid Communication
p. 169-171
CPI-0004Na, a new doxorubicin prodrug, reduces growth of 3LL-H61 carcinoma lung metastases in C57Bl/6 mice
Luc Dasnois, Karim Lebtahi, Jorge Abarca-Quinones, Nathalie Havaux, Samuel Dupont, Vincent Dubois and Andre Trouet
Abstract
Full Text (IP)
Perspective
Full Text (IP)